We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

A. Menarini Diagnostics S.r.l.

A. Menarini Diagnostics S.r.l. is fully committed to developing high tech diagnostics instruments and reagents to imp... read more Featured Products: More products

Download Mobile App

Menarini Introduces PRIME MDx All-in-One Molecular Diagnostics Solution

By LabMedica International staff writers
Posted on 23 May 2023
Print article
Image: PRIME MDx all-in-one, sample-to-result, fully automated solution (Photo courtesy of Menarini)
Image: PRIME MDx all-in-one, sample-to-result, fully automated solution (Photo courtesy of Menarini)

Menarini Diagnostics (Florence, Italy) is presenting its range of innovative professional diagnostics solutions in the field of molecular diagnostics, autoimmunity testing, hemoglobin analysis, and immunoassay testing at EuroMedLab Rome 2023.

The main highlight at Menarini's booth during this industry event is the brand new PRIME MDx all-in-one solution. This fully automated sample-to-result system is specifically designed to streamline laboratory workflows for real-time PCR diagnostic assays, offering exceptional efficiency, flexibility, and ease of use. With its automation and guided instrument setup, PRIME MDx minimizes manual intervention and ensures full sample traceability. Dedicated software enables automatic result generation and interpretation, leading to high-quality results, workflow standardization, and improved laboratory efficiency. The continuous workflow feature allows users to initiate a new loading process (extraction/setup) while a previous PCR is still running. PRIME MDx offers the flexibility to manage runs with various extraction reagent formats (prefilled or standard) and seamlessly integrates with existing IT infrastructure.

At the 2023 WordLab-EuroMedLab Congress, Menarini is also presenting the Zenit range of high-throughput innovations. This includes the Zenit PRIME random access chemiluminescence analyzer, catering to the autoimmunity laboratory's needs with its comprehensive panel of reagents and advanced features. The walk-away system boasts a throughput of up to 120 tests/hour, with continuous loading and random access to samples, specific and common reagents, and consumables, enabling efficient operation within an 8-hour timeframe (1000 tests).

In addition, Menarini is showcasing the winning combination of Zenit flow and Zenit fast in IIF (Indirect Immunofluorescence) slide processing and scanning. The Zenit flow automated IIF slide processor performs all necessary steps, from sample dilution to coverslip mounting, resulting in improved standardization and a flexible, optimized workflow within the laboratory. The Zenit flow is complimented by the Zenit fast automated diagnostics system for the acquisition, analysis, and storage of IFA (Immunofluorescence Assay) slides. It provides laboratories with an efficient solution to enhance the management of IFA tests, standardize the validation procedure, and reduce intra- and inter-laboratory variability. Some noteworthy features of Zenit fast include image autofocusing technology, whole-well scanning capability, software algorithms for IFA detection and pattern recognition, run-time efficiency, recognition of various ANA (Antinuclear Antibody) IFA patterns, and the ability to analyze different IFA substrates.

Related Links:
Menarini Diagnostics 

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Automatic ELISA Workstation

Print article


Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.